STRATA CRITICAL MEDICAL INC (SRTA:NASDAQ)
$4.98 0.19 (3.9666%)
Analysed STRATA CRITICAL MEDICAL INC (SRTA:NASDAQ) News Sources
How The Story Is Shifting For Strata Critical Medical (SRTA) After The Lower Fair Value Target
21-04-2026
yahoo.com
Strata Critical Medical Schedules First Quarter 2026 Earnings Conference Call
20-04-2026
yahoo.com
Niagen Bioscience And 2 Additional Promising Penny Stocks For Your Consideration
15-04-2026
yahoo.com
Cathie Wood’s Ark keeps selling one stock once again
15-04-2026
thestreet.com
Cathie Wood Dumps $10 Million of Mega Chip Stock
13-04-2026
yahoo.com
Strata Critical Medical to Present at the 25th Annual Needham Virtual Healthcare Conference
09-04-2026
yahoo.com
Strata Critical Medical, Inc. Q4 2025 Earnings Call Summary
04-03-2026
moby.co
Strata Critical Medical (SRTA) Earnings Call
03-03-2026
fool.com
Strata Critical Medical Announces Fourth Quarter 2025 Results
03-03-2026
yahoo.com
Strata Critical Medical Schedules Fourth Quarter 2025 Earnings Conference Call
10-02-2026
yahoo.com
What is the current price of STRATA CRITICAL MEDICAL INC (SRTA:NASDAQ)?
The current price of STRATA CRITICAL MEDICAL INC (SRTA:NASDAQ) is $4.98.
STRATA CRITICAL MEDICAL INC (SRTA:NASDAQ) absolute price change since previous trading day?
The absolute price change of STRATA CRITICAL MEDICAL INC (SRTA:NASDAQ) since the previous trading day is $0.19.
STRATA CRITICAL MEDICAL INC (SRTA:NASDAQ) percentage price change since previous trading day?
The percentage price change of STRATA CRITICAL MEDICAL INC (SRTA:NASDAQ) since the previous trading day is 3.9666%.
What is the most recent average sentiment score for STRATA CRITICAL MEDICAL INC (SRTA:NASDAQ)?
The most recent average sentiment score for STRATA CRITICAL MEDICAL INC (SRTA:NASDAQ) is 72 out of 100.
What is the most recent average sentiment for STRATA CRITICAL MEDICAL INC (SRTA:NASDAQ)?
The most recent sentiment for STRATA CRITICAL MEDICAL INC (SRTA:NASDAQ) is .
SEC-8K** Filing Available For STRATA CRITICAL MEDICAL INC (SRTA:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.